Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
about
Ultrasonic Dissection versus Conventional Dissection for Pancreatic Surgery: A Meta-AnalysisIndications for staging laparoscopy in pancreatic cancerRe-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasA systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer RegistrySelection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.Isoform-specific upregulation of palladin in human and murine pancreas tumors.Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasionmiR-29a-deficiency does not modify the course of murine pancreatic acinar carcinoma.A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform.Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data.Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.Transcatheter arterial chemoembolization for hepatic recurrence after curative resection of pancreatic adenocarcinoma.Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection.The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.Pancreatic ductal adenocarcinoma: long-term survival does not equal cureAnnexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.Matching high-risk recipients with marginal donor hearts is a clinically effective strategy.IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.Near-infrared fluorescence imaging in patients undergoing pancreaticoduodenectomy.Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival.A qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer.Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma.A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinomaSurvival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999.Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidatesGenetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer riskRobotic radiosurgery in pancreatic cancer: A systematic review.Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells.Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resectionDetermination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas.
P2860
Q26765939-704410D2-B6D6-47D5-B8E0-A0D418D60EE4Q26771578-4DE7968F-802F-4578-860E-27049FAF7874Q28075892-FCBE9150-978A-4492-8049-0A6472F3E757Q30240894-B64ED306-B0EB-4262-95AB-865E08E95F73Q30982758-8ABDEF53-1FF1-41DC-BFDB-E8386B20AEFFQ31163147-46A95C29-2010-4D50-BEAD-C9238D3FE610Q33570447-4C6B3CD5-EC81-4CBC-B1AF-B78CD304B38EQ33679644-9A51FF2C-F8D8-4105-B1D2-44D85F1D6137Q33688864-55BE66FD-273E-4F62-86D3-79ACB911DA4AQ33992146-E72984ED-0B80-439A-81F9-34073C98B173Q34080008-039A1660-76AA-413B-9B59-861527950E56Q34152694-B390D462-5492-476B-885B-EAC3C7526A46Q34183257-D0674B58-6A57-4150-9F9E-281B60BB2137Q34206717-1FE7EC01-F1F8-46A4-8595-B5E8F986B8B6Q34390304-E3826725-32BC-43C5-B433-4B8A1B3E58FBQ34536542-5F719D64-A1E4-49F5-B8F1-CB1FAFE9FEEAQ34570002-D36FD6A6-83CB-43FE-96D2-A28F61CC87CAQ34570963-2A17C58E-A1E3-4373-A730-D885C6A1A7C2Q34639984-58A7ECF6-02AD-44BF-A1C9-9C4E541397CEQ34674949-E9BCDEDF-FBC6-4798-A98C-00AF8C3039F9Q34732306-2A6DD9DE-66D3-40E5-8BB0-D3E6295D8914Q34797866-2B2BF75D-095C-432D-B8E7-C210E21A3077Q34896914-A3744B0F-53BC-426E-B483-8396C023B346Q34913900-FD09E579-AA03-4761-86D7-89D014F96B9FQ34958659-54F7008E-1288-4080-BC32-0F2DB80826B8Q35034722-6A24CFF3-BC74-4C8A-9016-EF01A730AF5EQ35089944-F343A28A-8FF7-4281-BE69-0D117301620BQ35102202-027360BF-7526-4FC7-8F74-EEA438F9476DQ35319001-FC9AE484-5562-43D8-98B7-93E36C370CEEQ35469061-DA95150E-C519-4F94-B2B8-D0020622F11AQ35627199-3BCC842F-A52A-4411-8FE5-902A6199ABC7Q35662806-ED6EED50-7E4A-4D48-9D11-2F1DDADDFDDAQ35747201-D8B1E956-7C2C-4C1D-A687-BAA9070B9884Q35769170-5327382B-FC92-4610-BC2F-0D8D6F1BFC92Q35798841-0A34EFAD-7B39-46D0-9EBD-3223FA417290Q35883577-496394E5-59F4-4AA9-AABF-2B90A54DFEB3Q35970200-646C6637-7D9B-4F2F-987D-C988171421F0Q35997632-1301A976-D8FB-4815-9872-0EBF1AD046DAQ36020137-07C8135F-0632-40C6-A279-E543016973D0Q36063267-DA3ED967-B829-44D9-B66E-A5C7B5FEEF61
P2860
Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prognostic factors in resected ...... is of actual 5-year survivors.
@ast
Prognostic factors in resected ...... is of actual 5-year survivors.
@en
type
label
Prognostic factors in resected ...... is of actual 5-year survivors.
@ast
Prognostic factors in resected ...... is of actual 5-year survivors.
@en
prefLabel
Prognostic factors in resected ...... is of actual 5-year survivors.
@ast
Prognostic factors in resected ...... is of actual 5-year survivors.
@en
P2093
P1476
Prognostic factors in resected ...... is of actual 5-year survivors.
@en
P2093
Bernard Langer
Bryce Taylor
Lloyd Smith
Maha Guindi
Paul Greig
Robert Gryfe
Robert Mackenzie
Sean P Cleary
Sherif Hanna
Steven Strasberg
P304
P356
10.1016/J.JAMCOLLSURG.2004.01.008
P577
2004-05-01T00:00:00Z